Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.
by Konstantina Zafeiropoulou
The European regulatory landscape for microbiome-based therapies is rapidly evolving. New frameworks like the SoHO Regulation aim to harmonize safety, quality, and access across countries. This article explores the current challenges, opportunities, and expert perspectives shaping the field.
by GMFH Editing Team
The role of diet and the gut microbiome in inflammatory bowel disease (IBD) continues to evolve, from shaping disease risk to supporting treatment strategies. In this interview with Richard Hansen and Chen Sarbagili, we discuss key misconceptions, emerging evidence, and what the future may hold for microbiome-based approaches in IBD.
by Andreu Prados
With nearly 240 participants from 27 countries, the 14th edition of GMFH World Summit covered basic, translational and clinical science supporting the integration of microbiome-targeted interventions into preventive and therapeutic strategies for gastrointestinal disorders, cardiometabolic diseases, and cancer.
by Heather Galipeau, Mark Wulczynski
A new study reveals that the benefits of dietary fiber in celiac disease depend not only on intake, but also on the presence of specific gut microbes capable of metabolizing it. These findings highlight the need for more personalized dietary strategies beyond the gluten-free diet.
by Andreu Prados
While “gut health” is becoming a popular term, mainly in media and marketing claims but also in the clinical context, researchers have not yet nailed down a definition. Now, a global group of 13 scientists and clinicians updates a consensus definition of gut health and implications from bench to bedside.
The management of disorders of gut-brain interaction based on their causes was a central topic addressed at NeuroGASTRO 2025. In this video interview, Dr. Javier Santos delves into the role of mast cells in postprandial symptoms and the present and future of microbiome-based interventions for bowel disorders.
by Manon Oliero
Much of nutrition science has centred on what we put on our plate, yet when we choose to eat may be just as consequential. Intermittent fasting (IF) has gained attention as a strategy that may support metabolic health while also reshaping microbial rhythms, gut hormone secretion, and intestinal function. The growing interest surrounding this approach raises an essential question for clinical practice: does IF truly translate into measurable benefits?
by GMFH Editing Team
Gut microbiome-related interventions for the management of disorders of gut-brain interaction were on the agenda of NeuroGASTRO 2025. In this video interview, Dr. Juan M. Mendive delves into the role of the gut microbiome for improving outcomes of primary care patients with IBS.
by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines show that psyllium, certain probiotic strains and magnesium oxide supplements can help to improve constipation.
by Nathalie Rolhion, Harry Sokol
Antibiotic treatments can profoundly disrupt gut microbiome structure and function. This article reviews new findings showing how Saccharomyces boulardii CNCM I-745 helps preserve microbial activity and metabolic resilience during antibiotic stress, with insights from advanced in vitro models and immune assays.
